Nkarta, Inc. (NKTX) Discusses Initial NKX019 Clinical Data in Myositis and Systemic Sclerosis Transcript

🇺🇸 Seeking Alpha (US) —

AI Summary

Nkarta discussed initial clinical data for NKX019 in patients with myositis and systemic sclerosis. The provided article does not include specific trial results or further details.

Markets Health Nkarta NKX019 clinical data myositis systemic sclerosis biotechnology

Read original source →